Nuwellis (NUWE) Liabilities and Shareholders Equity (2011 - 2026)
Nuwellis' (NUWE) quarterly Liabilities and Shareholders Equity came in at $7.0 million in Q1 2026, down 0.64% YoY from $7.0 million in Q1 2025, and up 13.78% on a QoQ basis from $6.1 million in Q4 2025.
Nuwellis (NUWE) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
Nuwellis (NUWE) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $7.0 million in Q1 2026.
- Quarterly Liabilities and Shareholders Equity fell 0.64% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.3 million (up 1.6% YoY) and the FY2025 annual result came in at $6.1 million, down 37.98% from the prior year.
- Liabilities and Shareholders Equity grew to $7.0 million in Q1 2026, from $6.1 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $26.1 million in Q1 2022 to a low of $6.1 million in Q4 2025.
- A 5-year average of $12.5 million and a median of $9.8 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity sank 63.95% — and 2025, when it soared 48.65%.
- Tracing NUWE's Liabilities and Shareholders Equity over 5 years: stood at $24.7 million in 2022, then plunged by 60.4% to $9.8 million in 2023, then increased by 0.96% to $9.9 million in 2024, then sank by 37.98% to $6.1 million in 2025, then advanced by 13.78% to $7.0 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $7.0 million (Q1 2026), $6.1 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Nuwellis | 203,898.38 | -3.72 Mn | 1.50 Mn | 9.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.13 Mn |
| Mar 31, 2026 | 6.96 Mn |
| Dec 31, 2025 | 6.12 Mn |
| Sep 30, 2025 | 7.98 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Mar 31, 2025 | 7.01 Mn |
| Dec 31, 2024 | 9.86 Mn |
| Sep 30, 2024 | 6.73 Mn |
| Jun 30, 2024 | 6.19 Mn |
| Mar 31, 2024 | 6.66 Mn |
| Dec 31, 2023 | 9.77 Mn |
| Sep 30, 2023 | 11.43 Mn |
| Jun 30, 2023 | 15.55 Mn |
| Mar 31, 2023 | 18.48 Mn |
| Dec 31, 2022 | 24.67 Mn |
| Sep 30, 2022 | 18.44 Mn |
| Jun 30, 2022 | 22.00 Mn |
| Mar 31, 2022 | 26.11 Mn |
| Dec 31, 2021 | 30.42 Mn |
| Sep 30, 2021 | 34.10 Mn |